1. Patients and Caregivers
  2. Life Effects
  3. Let’s talk about Multiple Sclerosis (MS)

Let’s talk about Multiple Sclerosis (MS)

Let’s talk about Multiple Sclerosis (MS)

Multiple sclerosis is a chronic, unpredictable and progressive disease of the Central Nervous System, which is made up of the brain and spinal cord.

Find out more about the disease here, including the different types of MS, what the symptoms are, who is affected, how they cope and Teva’s expertise in this area.

Image for infographic, full information can be downloaded in PDF format

Download PDF version

Find out more

  • Patient safety is at the heart of all we do and one of our core principles. You can find out more about Teva’s patient promise here.
  • We’re hiring! Click here to discover the latest vacancies at Teva Pharmaceuticals.

The individual(s) who have written and created the content in and whose images appear in this article have been paid by Teva Pharmaceuticals for their contributions. This content represents the opinions of the contributor and does not necessarily reflect those of Teva Pharmaceuticals. Similarly, Teva Pharmaceuticals does not review, control, influence or endorse any content related to the contributor's websites or social media networks. This content is intended for informational and educational purposes and should not be considered medical advice or recommendations. Consult a qualified medical professional for diagnosis and before beginning or changing any treatment regimen​. 

This content was originally published by Teva on the Life Effects website, where additional articles and content are available for US and European audiences.

For US residents only: https://lifeeffects.teva/us/
For European residents only: https://lifeeffects.teva/eu/

I found this article:

Share this article:

You might also be interested in...


How To Keep Active at Home with MS

By Trishna Bharadia
Read more

8 Ways COVID-19 Affected My Healthcare Routine

By Robert Joyce
Read more

COVID-19: What I Hope the World Remembers After COVID-19

By Barbara Stensland
Read more